Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KT Medical Service PCLBKK:KTMS -2.82%70 Debt-to-EBITDA is 0.86 as of Mar. 2026, which is 13% below its 10-year median of 0.99. GuruFocus rates BKK:KTMS with a GF Score™ of 70/100 and a GF Value™ of ฿3.08 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 479 Healthcare Providers & Services companies, KT Medical Service PCL ranks better than 74.74% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for KT Medical Service PCL's Debt-to-EBITDA or its related term are showing as below:
BKK:KTMS'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -63.83 Med: 0.99 Max: 1.75
Current: 0.75
During the past 6 years, the highest Debt-to-EBITDA Ratio of KT Medical Service PCL was 1.75. The lowest was -63.83. And the median was 0.99.
BKK:KTMS's Debt-to-EBITDA is ranked better than 74.74% of 479
companies
in the Healthcare Providers & Services industry
Industry Median: 2.18
vs BKK:KTMS: 0.75
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
KT Medical Service PCL Debt-to-EBITDA Related Terms
KT Medical Service PCL Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for KT Medical Service PCL's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:KTMS vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, KT Medical Service PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KT Medical Service PCL Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, KT Medical Service PCL's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where KT Medical Service PCL's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
KT Medical Service PCL (BKK:KTMS) has a Debt-to-EBITDA of 0.86 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on KT Medical Service PCL. This is 13% below median its historical median of 0.99. According to the industry distribution chart, KT Medical Service PCL ranks #121 out of 479 companies in the Healthcare Providers & Services industry, placing it in the top 25.3%.
Is KT Medical Service PCL's Debt-to-EBITDA too high?
KT Medical Service PCL's current Debt-to-EBITDA of 0.86 is 13% below median its 10-year median of 0.99. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.18. KT Medical Service PCL's value of 0.86 is 60.6% below this industry median. Based on the distribution chart, KT Medical Service PCL ranks #121 out of 479 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, KT Medical Service PCL has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does KT Medical Service PCL's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, KT Medical Service PCL ranks #121 out of 479 companies for Debt-to-EBITDA. This puts KT Medical Service PCL in the upper half of its industry. The industry median Debt-to-EBITDA is 2.18. KT Medical Service PCL's value of 0.86 is 60.6% below this benchmark. While the company's 10-year median is 0.99 vs. the industry median of 2.18, KT Medical Service PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.18, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KT Medical Service PCL's current Debt-to-EBITDA of 0.86 is 60.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on KT Medical Service PCL. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KT Medical Service PCL's current Debt-to-EBITDA is 0.86, which is 13% below median its own 10-year median of 0.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KT Medical Service PCL stock overvalued right now?
Based on GuruFocus' analysis, KT Medical Service PCL (BKK:KTMS) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿3.08, compared to a current price of ฿1.38 — trading 55.2% below its estimated fair value. The current Debt-to-EBITDA is 0.86, which is 13% below median its 10-year median of 0.99 and 60.6% below the Healthcare Providers & Services industry median of 2.18. KT Medical Service PCL's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For KT Medical Service PCL (BKK:KTMS), the current Debt-to-EBITDA is 0.86 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KT Medical Service PCL (BKK:KTMS) Overvalued in 2026?
Based on GuruFocus' analysis, KT Medical Service PCL stock appears to be undervalued.
The current stock price of ฿1.38 is trading 55.2% below its estimated GF Value™ of ฿3.08.
GuruFocus considers KT Medical Service PCL to be Significantly Undervalued.
Key valuation signals for BKK:KTMS:
Debt-to-EBITDA: 0.86 (13% below median its 10-year median of 0.99)
GF Value™: ฿3.08 vs. price of ฿1.38 (55.2% below fair value)
Industry Position: 60.6% below the Healthcare Providers & Services median (#121 of 479)
No single metric tells the full story. See the BKK:KTMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KT Medical Service PCL operates in Thailand and engages in hemodialysis center, design, assembly and installation of pure water treatment system and service preventive maintenance of pure water treatment system for commercial and residential sectors, the industrial and original equipment manufacturing of water system sector and medical service sector. The company's segments include Service of hemodialysis, Service of design and installation of pure water treatment system and the service preventive maintenance of pure water treatment system for medical service, and Services of design and installation of pneumatic tube system of equipment for medical service. It derives majority of the revenue from Service of hemodialysis segment.
70GF Score
Get the complete analysis for BKK:KTMS
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KTMS has been successfully added to your 
